Emilie Zoltick is a Research Scientist in the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. Dr. Zoltick received her MPH from Boston University School of Public Health and her ScD from the Harvard T.H. Chan School of Public Health in epidemiology with a focus on cancer prevention and control. She completed her postdoctoral training at Boston University and the Genomes2People research program at Brigham and Women’s Hospital.
Dr. Zoltick’s research interests include genetic and genomic screening and the medical and behavioral outcomes of genetic testing in healthy populations. She works with Dr. Kurt Christensen evaluating the application and impact of predispositional genomic screening in health care settings. She also works with Dr. Mei-Sing Ong to investigate race and ethnicity underrepresentation in pediatric clinical trials.